TNF and disease arising from reactivation of latent virus: This variability is reflected in the experimental J-Lat cell line models for latent infection, where clones containing distinct integration sites for the HIV-1 provirus respond with different levels of virus reactivation to the same stimulant, such as PMA or TNF-α [23,34,46].